Legal information regarding Actos

A Third Actos Generic to Begin Posing Cancer Risk

A federal judge has said a third company can begin selling Actos generics immediately – even after the Food and Drug Administration (FDA) said otherwise. Watson Pharmaceuticals was initially denied the approval to sell the …

Consumer Reports: Avoid Actos — and its Generics — At All Costs

Even after the FDA approved generic versions of Actos in August, a nonprofit consumer watchdog group said you should “skip” them. The FDA approved pioglitazone hydrochloride tablets to treat type 2 diabetes this summer, despite …

Canadians Taking a Stand Against Actos

Jimmy Whyte, a Canadian man, petitioned for a class action lawsuit against Takeda Pharmaceuticals and Eli Lilly & Co., the manufacturers and distributors of Actos. Whyte had been taking Actos for type 2 diabetes starting …